trending Market Intelligence /marketintelligence/en/news-insights/trending/0Xqirf_jBafTGmYum8DRQg2 content esgSubNav
In This List

BioCryst Pharmaceuticals appoints board chairman

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


BioCryst Pharmaceuticals appoints board chairman

BioCryst Pharmaceuticals Inc. appointed Robert Ingram as chairman of its board of directors.

Ingram has been a member of the company's board since 2015. He replaces George Abercrombie, who will step down as chairman but continue to be a member of the board.